187 related articles for article (PubMed ID: 18649302)
1. Natural inhibitors of DNA topoisomerase I with cytotoxicities.
Han HJ; Tan NH; Zeng GZ; Fan JT; Huang HQ; Ji CJ; Jia RR; Zhao QS; Zhang YJ; Hao XJ; Wang LQ
Chem Biodivers; 2008 Jul; 5(7):1364-8. PubMed ID: 18649302
[TBL] [Abstract][Full Text] [Related]
2. 2,4,6-Trisubstituted pyridines: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.
Basnet A; Thapa P; Karki R; Na Y; Jahng Y; Jeong BS; Jeong TC; Lee CS; Lee ES
Bioorg Med Chem; 2007 Jul; 15(13):4351-9. PubMed ID: 17493824
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of nitrated indenoisoquinolines as topoisomerase I inhibitors.
Morrell A; Antony S; Kohlhagen G; Pommier Y; Cushman M
Bioorg Med Chem Lett; 2004 Jul; 14(14):3659-63. PubMed ID: 15203138
[TBL] [Abstract][Full Text] [Related]
4. Oxiranylmethyloxy or thiiranylmethyloxy-azaxanthones and -acridone analogues as potential topoisomerase I inhibitors.
Cho HJ; Jung MJ; Kwon Y; Na Y
Bioorg Med Chem Lett; 2009 Dec; 19(23):6766-9. PubMed ID: 19836231
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of indenoisoquinoline topoisomerase I inhibitors using a hollow fiber assay.
Morrell A; Jayaraman M; Nagarajan M; Fox BM; Meckley MR; Ioanoviciu A; Pommier Y; Antony S; Hollingshead M; Cushman M
Bioorg Med Chem Lett; 2006 Aug; 16(16):4395-9. PubMed ID: 16750365
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of DNA topoisomerase I and growth inhibition of human cancer cell lines by an oleanane from Junellia aspera (Verbenaceae).
Pungitore CR; Padron JM; Leon LG; Garcia C; Ciuffo GM; Martin VS; Tonn CE
Cell Mol Biol (Noisy-le-grand); 2007 May; 53(3):13-7. PubMed ID: 17531144
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and cytotoxic activity of a new series of topoisomerase I inhibitors.
Dallavalle S; Gattinoni S; Mazzini S; Scaglioni L; Merlini L; Tinelli S; Beretta GL; Zunino F
Bioorg Med Chem Lett; 2008 Feb; 18(4):1484-9. PubMed ID: 18248813
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of DNA topoisomerases I and II and cytotoxicity by lignans from Saururus chinensis.
Lee YK; Seo CS; Lee CS; Lee KS; Kang SJ; Jahng Y; Chang HW; Son JK
Arch Pharm Res; 2009 Oct; 32(10):1409-15. PubMed ID: 19898804
[TBL] [Abstract][Full Text] [Related]
9. DNA topoisomerase I inhibitory alkaloids from Corydalis saxicola.
Cheng X; Wang D; Jiang L; Yang D
Chem Biodivers; 2008 Jul; 5(7):1335-44. PubMed ID: 18649321
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of gibberellin derivatives with anti-tumor bioactivities.
Chen J; Sun Z; Zhang Y; Zeng X; Qing C; Liu J; Li L; Zhang H
Bioorg Med Chem Lett; 2009 Sep; 19(18):5496-9. PubMed ID: 19679470
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and topoisomerase poisoning activity of A-ring and E-ring substituted luotonin A derivatives.
Nacro K; Zha CC; Guzzo PR; Jason Herr R; Peace D; Friedrich TD
Bioorg Med Chem; 2007 Jun; 15(12):4237-46. PubMed ID: 17418582
[TBL] [Abstract][Full Text] [Related]
12. CKD-602, a camptothecin derivative, inhibits proliferation and induces apoptosis in glioma cell lines.
Kim YY; Park CK; Kim SK; Phi JH; Kim JH; Kim CY; Wang KC; Cho BK
Oncol Rep; 2009 Jun; 21(6):1413-9. PubMed ID: 19424618
[TBL] [Abstract][Full Text] [Related]
13. Novel stable camptothecin derivatives replacing the E-ring lactone by a ketone function are potent inhibitors of topoisomerase I and promising antitumor drugs.
Lansiaux A; Léonce S; Kraus-Berthier L; Bal-Mahieu C; Mazinghien R; Didier S; David-Cordonnier MH; Hautefaye P; Lavielle G; Bailly C; Hickman JA; Pierré A
Mol Pharmacol; 2007 Aug; 72(2):311-9. PubMed ID: 17494837
[TBL] [Abstract][Full Text] [Related]
14. Structural modification of 3-arylisoquinolines to isoindolo[2,1-b]isoquinolinones for the development of novel topoisomerase 1 inhibitors with molecular docking study.
Van HT; Cho WJ
Bioorg Med Chem Lett; 2009 May; 19(9):2551-4. PubMed ID: 19328687
[TBL] [Abstract][Full Text] [Related]
15. Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome.
Vispé S; Vandenberghe I; Robin M; Annereau JP; Créancier L; Pique V; Galy JP; Kruczynski A; Barret JM; Bailly C
Biochem Pharmacol; 2007 Jun; 73(12):1863-72. PubMed ID: 17391647
[TBL] [Abstract][Full Text] [Related]
16. Dimethoxybenzo[i]phenanthridine-12-carboxylic acid derivatives and 6H-dibenzo[c,h][2,6]naphthyridin-5-ones with potent topoisomerase I-targeting activity and cytotoxicity.
Ruchelman AL; Zhu S; Zhou N; Liu A; Liu LF; LaVoie EJ
Bioorg Med Chem Lett; 2004 Nov; 14(22):5585-9. PubMed ID: 15482929
[TBL] [Abstract][Full Text] [Related]
17. Disulfiram is a potent in vitro inhibitor of DNA topoisomerases.
Yakisich JS; Sidén A; Eneroth P; Cruz M
Biochem Biophys Res Commun; 2001 Nov; 289(2):586-90. PubMed ID: 11716515
[TBL] [Abstract][Full Text] [Related]
18. Topoisomerase I and II inhibitory constituents from the bark of Tilia amurensis.
Choi JY; Seo CS; Zheng MS; Lee CS; Son JK
Arch Pharm Res; 2008 Nov; 31(11):1413-8. PubMed ID: 19023537
[TBL] [Abstract][Full Text] [Related]
19. In vitro assessment of novel transcription inhibitors and topoisomerase poisons in rhabdomyosarcoma cell lines.
Wolf SJ; Wakelin LP; He Z; Stewart BW; Catchpoole DR
Cancer Chemother Pharmacol; 2009 Nov; 64(6):1059-69. PubMed ID: 19277661
[TBL] [Abstract][Full Text] [Related]
20. L-proline analogues of anthraquinone-2-carboxylic acid: cytotoxic activity in breast cancer MCF-7 cells and inhibitory activity against topoisomerase I and II.
Bielawska A; Kosk K; Bielawski K
Pol J Pharmacol; 2001; 53(3):283-7. PubMed ID: 11785929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
